Related Experiment Video
Updated: Nov 7, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Mevalonate Kinase-Associated Diseases: Hunting for Phenotype-Genotype Correlation
Guilaine Boursier1, Cécile Rittore1, Florian Milhavet1,2
1Department of Medical Genetics, Rare Diseases and Personalized Medicine, Rare and Autoinflammatory Diseases Unit, CHU, 34295 Montpellier, France.
Abstract:
Mevalonate kinase-associated diseases (MKAD) are caused by pathogenic mutations in the mevalonate kinase gene (MVK) and encompass several phenotypically different rare and hereditary autoinflammatory conditions. The most serious is a recessive systemic metabolic disease called mevalonic aciduria, and the most recently recognized is disseminated superficial actinic porokeratosis, a dominant disease limited to the skin. To evaluate a possible correlation between genotypes and (1) the different MKAD clinical subtypes or (2) the occurrence of severe manifestations, data were reviewed for all patients with MVK variants described in the literature (N = 346), as well as those referred to our center (N = 51). The genotypes including p.(Val377Ile) (homozygous or compound heterozygous) were more frequent in mild systemic forms but were also sometimes encountered with severe disease. We confirmed that amyloidosis was more prevalent in patients compound heterozygous for p.(Ile268Thr) and p.(Val377Ile) than in others and revealed new associations. Patients homozygous for p.(Leu264Phe), p.(Ala334Thr) or compound heterozygous for p.(His20Pro) and p.(Ala334Thr) had increased risk of severe neurological or ocular symptoms. All patients homozygous for p.(Leu264Phe) had a cataract. The variants associated with porokeratosis were relatively specific and more frequently caused a frameshift than in patients with other clinical forms (26% vs. 6%). We provide practical recommendations focusing on phenotype-genotype correlation in MKAD that could be helpful for prophylactic management.
Insights
Mevalonate kinase-associated diseases (MKAD) result from MVK gene mutations. Genotype-phenotype correlations help predict disease severity and guide management for these rare autoinflammatory conditions.
Area of Science:
- Genetics
- Immunology
- Rare Diseases
Background:
- Mevalonate kinase-associated diseases (MKAD) encompass a spectrum of rare autoinflammatory conditions caused by mutations in the mevalonate kinase gene (MVK).
- These conditions range from severe systemic metabolic disorders like mevalonic aciduria to skin-limited diseases such as disseminated superficial actinic porokeratosis.
Purpose of the Study:
- To investigate genotype-phenotype correlations in MKAD.
- To determine if specific MVK variants are associated with distinct clinical subtypes or disease severity.
Main Methods:
- A comprehensive review of literature data (N=346) and patient data from a referral center (N=51) with MVK variants.
- Analysis of genotype-phenotype relationships, focusing on specific MVK mutations and their clinical manifestations.
Main Results:
- Certain genotypes, like p.(Val377Ile), were linked to milder systemic forms but also observed in severe cases.
- Specific compound heterozygous variants (p.(Ile268Thr) and p.(Val377Ile)) increased amyloidosis risk.
- Homozygous p.(Leu264Phe) or p.(Ala334Thr), and compound heterozygous p.(His20Pro)/p.(Ala334Thr) correlated with severe neurological/ocular symptoms; p.(Leu264Phe) homozygosity invariably led to cataracts.
- Porokeratosis-associated variants were specific and more likely to be frameshift mutations.
Conclusions:
- Genotype-phenotype correlations in MKAD are crucial for understanding disease variability.
- Identifying specific MVK variants can predict disease severity and guide prophylactic management strategies.
- These findings aid in the clinical management and counseling of patients with MKAD.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Inborn Errors of Metabolism
Animal Mitochondrial Genetics
Pleiotropy
Pedigree Analysis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug